• Return to Headlines

Medifast Shares Up 19.0% Since SmarTrend's Buy Recommendation (MED)

By David Diaz

SmarTrend identified an Uptrend for Medifast (NYSE:MED) on July 11th, 2016 at $34.18. In approximately 3 months, Medifast has returned 19.02% as of today's recent price of $40.68.

In the past 52 weeks, shares of Medifast have traded between a low of $26.14 and a high of $40.92 and are now at $40.68, which is 56% above that low price. The 200-day and 50-day moving averages have moved 0.10% higher and 0.58% higher over the past week, respectively.

Medifast, Inc. combines physician-supervised weight loss programs with nutritional supplements and multidisciplinary patient education programs. The Company provides an Internet-based physician and medical practitioner network to consumers. Medifast also provides a corporate wellness program for large corporations, associations, and their health insurance carriers.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Medifast shares.

Log in and add Medifast (MED) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights medifast

Ticker(s): MED